Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ALTEX

Showing results (451-460 of 1,366) with videos related to

Pageof 137
Sort By:
ALTEX|February 15, 2001
[Development of an alternative method to the monkey neurovirulence test for oral poliovirus vaccines]Arthur Kaul, Micha Nübling, Martina Kempfer, et al.
ALTEX|February 15, 2001
Use of in Vitro Correlates for Selection of Candidate Immunosuppressive Antibodies Prior to a Primate Transplant ModelMiriam A. Ossevoort, Maria C. Noort, Almuth Radzikowski, et al.
ALTEX|February 15, 2001
[Optimisation and establishing of serological methods for the potency testing of immunglobulins against Clostridium tetani-toxin]Elvira Ebert, Annett Abu Karim, Tanja Kayser, et al.
ALTEX|February 15, 2001
Pertussis Serological Potency Test as an Alternative to the Intracerebral Mouse Protection Test: Development, Evaluation and ValidationArno van Der Ark, Ineke von Straaten-Van De Kappelle, Coenraad F. M. Hendriksen
ALTEX|February 15, 2001
[Humane endpoints as a replacement for the estimation of lethality rates in the potency testing of rabies vaccines]Klaus Cubetaler, David Morton, Coenraad F. M. Hendriksen
ALTEX|February 15, 2001
[Detection of extraneous virus in live vaccines]Beate Krämer, Petra Rübmann, Karin Cubetaler Klaus Duchow
ALTEX|February 15, 2001
[Detection of Clostridium novyi type B alpha toxin using cell culture systems]Erika Borrmann, Frank Schulze
ALTEX|February 15, 2001
[Cytokine release after administration of endotoxin containing vaccines]Martina Ecker, Günter Müller
ALTEX|February 15, 2001
[Testing fish vaccines with an in vitro lymphocyte blastogenesis assay]Ralf Peter Pund, Katrin Nold, Elke Henrion
ALTEX|February 15, 2001
[: A comparison of commercially available adjuvants in BALB/c-mice immunised with a weekly immunogenic peptide]Christine Zwerger, Roland Plesker, Kyriakos Papadopulos, et al.
Pageof 137

Showing results (451-460 of 1,366) with videos related to

Sort By:
Pageof 137
ALTEX|February 15, 2001
[Development of an alternative method to the monkey neurovirulence test for oral poliovirus vaccines]Arthur Kaul, Micha Nübling, Martina Kempfer, et al.
ALTEX|February 15, 2001
Use of in Vitro Correlates for Selection of Candidate Immunosuppressive Antibodies Prior to a Primate Transplant ModelMiriam A. Ossevoort, Maria C. Noort, Almuth Radzikowski, et al.
ALTEX|February 15, 2001
[Optimisation and establishing of serological methods for the potency testing of immunglobulins against Clostridium tetani-toxin]Elvira Ebert, Annett Abu Karim, Tanja Kayser, et al.
ALTEX|February 15, 2001
Pertussis Serological Potency Test as an Alternative to the Intracerebral Mouse Protection Test: Development, Evaluation and ValidationArno van Der Ark, Ineke von Straaten-Van De Kappelle, Coenraad F. M. Hendriksen
ALTEX|February 15, 2001
[Humane endpoints as a replacement for the estimation of lethality rates in the potency testing of rabies vaccines]Klaus Cubetaler, David Morton, Coenraad F. M. Hendriksen
ALTEX|February 15, 2001
[Detection of extraneous virus in live vaccines]Beate Krämer, Petra Rübmann, Karin Cubetaler Klaus Duchow
ALTEX|February 15, 2001
[Detection of Clostridium novyi type B alpha toxin using cell culture systems]Erika Borrmann, Frank Schulze
ALTEX|February 15, 2001
[Cytokine release after administration of endotoxin containing vaccines]Martina Ecker, Günter Müller
ALTEX|February 15, 2001
[Testing fish vaccines with an in vitro lymphocyte blastogenesis assay]Ralf Peter Pund, Katrin Nold, Elke Henrion
ALTEX|February 15, 2001
[: A comparison of commercially available adjuvants in BALB/c-mice immunised with a weekly immunogenic peptide]Christine Zwerger, Roland Plesker, Kyriakos Papadopulos, et al.
Pageof 137